rewirebio.iobenchmarks
Configuration

ANEVA-H (Silverstein et al. 2026)

Configuration of ANEVA-h: phASER v1.1.1 gene-level ASE from EAGLE v2.4.1-phased genotypes; ANEVADOT_test with default parameters; GTEx v8 muscle reference (706 samples); >= 10 reads per gene; BH FDR < 0.05.

1 evaluation · 9 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

1 evaluation · 9 results. Different protocols are not a single leaderboard.

Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE) · Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)

Sorted by Accuracy (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9)) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationAccuracy (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))F1 (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))False negatives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))False positives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))MCC (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))Precision (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))Recall (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))True negatives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))True positives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
ANEVA-H (Silverstein et al. 2026)Evaluation0.4620.58834-0.1840.5560.62515
All 9 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
0.462 Accuracy (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell F9, row 'ANEVA-H', column 'Accuracy'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
0.588 F1 (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell I9, row 'ANEVA-H', column 'F1'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
3 False negatives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell C9, row 'ANEVA-H', column 'False Negatives'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
4 False positives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell E9, row 'ANEVA-H', column 'False Positives'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
-0.184 MCC (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell J9, row 'ANEVA-H', column 'MCC'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
0.556 Precision (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell G9, row 'ANEVA-H', column 'Precision'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
0.625 Recall (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell H9, row 'ANEVA-H', column 'Recall'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
1 True negatives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell D9, row 'ANEVA-H', column 'True Negatives'
Configuration: ANEVA-H (Silverstein et al. 2026)Protocol: Recovery of known allelic-imbalance genes and outlier calls in true-negative samples, patient muscle RNA-seq (Silverstein et al. Table S9, ANEVA-H and MAE)
Dataset: NIH neuromuscular diagnosed RNA-seq truth set (Silverstein et al. 2026)
5 True positives (positives per known event or gene, negatives per true-negative sample; aggregated across the tissue sets each tool was run on (Table S9))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ANEVA-H on the NIH neuromuscular diagnosed RNA-seq truth set (allelic-imbalance)

rna-splicing-20261011-silverstein2026-protocol-allelic-imbalance

Aggregation: Not reported

Benchmarking RNA-seq Tools for Real-World Diagnostic Applications (Silverstein et al., medRxiv 2026); Silverstein et al. 2026 Supplemental Tables S1-S10 (medRxiv media-3.xlsx) · Table S9 (sheet 'Table S9') cell B9, row 'ANEVA-H', column 'True Positives'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Use this configuration

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: rna-splicing-20261011-silverstein2026-config-aneva-h

areas
rna-transcriptomes
contexts
clinical_research
method types
conventional_pipeline
reported name
ANEVA-H
foundation model eligible
false
version
ANEVA-DOT R package (version unreported)
parameters
phASER v1.1.1 gene-level ASE from EAGLE v2.4.1-phased genotypes; ANEVADOT_test with default parameters; GTEx v8 muscle reference (706 samples); >= 10 reads per gene; BH FDR < 0.05
access reuse
Open-source tool; run by the authors on the NIH Biowulf cluster
source locator
Methods 'Allelic Imbalance Tools'; Table S9 row label
provenance note
ANEVA-H as run in the Silverstein et al. 2026 benchmark.
Related records

Suggest a correction